1-(4-(4-(5-((4-(methylsulfonyl)piperazin-1-yl)methyl)thiophen-2-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(1H-pyrazol-5-yl)urea

ID: ALA5272452

Chembl Id: CHEMBL5272452

Max Phase: Preclinical

Molecular Formula: C27H32N10O4S2

Molecular Weight: 624.75

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)N1CCN(Cc2ccc(-c3nc(-c4ccc(NC(=O)Nc5ccn[nH]5)cc4)nc(N4CCOCC4)n3)s2)CC1

Standard InChI:  InChI=1S/C27H32N10O4S2/c1-43(39,40)37-12-10-35(11-13-37)18-21-6-7-22(42-21)25-31-24(32-26(33-25)36-14-16-41-17-15-36)19-2-4-20(5-3-19)29-27(38)30-23-8-9-28-34-23/h2-9H,10-18H2,1H3,(H3,28,29,30,34,38)

Standard InChI Key:  HGFWFEHZQQWXSB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5272452

    ---

Associated Targets(Human)

PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MET Tclin Hepatocyte growth factor receptor (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 624.75Molecular Weight (Monoisotopic): 624.2049AlogP: 2.55#Rotatable Bonds: 8
Polar Surface Area: 161.57Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.80CX Basic pKa: 5.89CX LogP: 3.23CX LogD: 3.20
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.27Np Likeness Score: -2.14

References

1. Xu S, Luo L, Sun X, Yang Y, Guo Q, Jiang Z, Wu Y..  (2023)  Design, synthesis and antitumor activity of novel thiophene- triazine derivatives bearing arylurea unit as potent PI3K/mTOR inhibitorss.,  78  [PMID:36599263] [10.1016/j.bmc.2022.117133]

Source